Currently out of the existing stock ratings of Sel Hardy, 1 are a HOLD (100%).

Sel Hardy

Work Performance Price Targets & Ratings Chart

Analyst Sel Hardy, currently employed at CFRA,

Sel Hardy’s has documented 2 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on PFE, Pfizer at 07-Oct-2024.

Wall Street Analyst Sel Hardy

Analyst best performing recommendations are on PFE (PFIZER).
PFE Pfizer

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 23-Feb-2024

$31

$4.21 (15.71%)

$35

14 days ago
(07-Aug-2026)

20/30 (66.67%)

$4.24 (15.84%)

664

0.85

Buy Since 19-Nov-2021

$30

$3.21 (11.98%)

$30

1 months 8 days ago
(13-Jul-2026)

0/19 (0%)

$5.52 (22.55%)

0

Hold Since 30-Jul-2019

$26

$-0.79 (-2.95%)

$26

1 months 11 days ago
(10-Jul-2026)

6/7 (85.71%)

$1.83 (7.57%)

489

0.96

Hold Since 01-Jun-2020

$28

$1.21 (4.52%)

$30

1 months 13 days ago
(08-Jul-2026)

9/18 (50%)

$3.95 (16.42%)

1020

0.55

Buy Since 17-Mar-2026

$28

$1.21 (4.52%)

$32

1 months 15 days ago
(06-Jul-2026)

0/3 (0%)

$4.28 (18.04%)

0

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Sel Hardy?

On 2024

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?